Advertisement
News
Advertisement

Cellceutix to launch phase 1 trial for cancer drug

Mon, 09/24/2012 - 12:00am
Mass High Tech: The Journal of New England Technology

Cellceutix Corporation (OTCBB: CTIX) will launch its first human trial for its lead product, a potential therapy for advanced solid tumors at Dana-Farber Cancer Institute and Beth Israel Deaconess Medical Center, after a nine-month delay.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading